ロード中...
Multiple Myeloma: 2016 update on Diagnosis, Risk-stratification and Management
DISEASE OVERVIEW: Multiple myeloma accounts for approximately 10% of hematologic malignancies. DIAGNOSIS: The diagnosis requires ≥10% clonal bone marrow plasma cells or a biopsy proven plasmacytoma plus evidence of one or more multiple myeloma defining events (MDE): CRAB (hypercalcemia, renal failur...
保存先:
| 出版年: | Am J Hematol |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5291298/ https://ncbi.nlm.nih.gov/pubmed/27291302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24402 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|